CIMB Research downgraded Parkway Life Real Estate Investment Trust, which owns healthcare assets, to ‘neutral’ from ‘outperform’, citing high valuations as it trades at a premium.
Units of Parkway Life were down 0.5 percent at S$1.925, and have gained 8.2 percent so far this year.
“The market has rewarded the stock with a handsome defensive premium. At 30 percent premium over book and yield compression to 5 percent, we struggle to see significant upside,” said CIMB.
However, CIMB raised its target price to S$2.11 from S$1.96, taking into account a lower discount rate of 7 percent, and said possible acquisitions in Malaysia and Australia could be a re-rating catalyst.
In Japan, the plans of Parkway Life’s management to upgrade assets is a compelling strategy for long-term growth, said CIMB.
To read a statement, click
Reporting by xx in Singapore; firstname.lastname.thomsonreuters.com